Sundar has settled a case with markets regulator Sebi by returning the advisory fee and disgorging over Rs 6 crore. The case related to PR Sundar and Mangayarkarasi Sundar, promoters of Mansun Consulting, offering investment advice without the necessary registration from the market regulator.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418